Landmark study links tumour evolution to prostate cancer severity

Study shows that environmental exposures such as air pollution are more determinant of respiratory health than inherited genetics

OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic

Innovative study brings next-generation genomic sequencing to more Ontario cancer patients

New data resource centre will help better understand links between birth defects and childhood cancer

Researchers disprove link between vasectomies and prostate cancer using Ontario health data

OICR partners with Israeli university to create new cancer genomics and immunity program

Dr. John Dick elected as 2016 Fellow of the AACR Academy

International Cancer Genome Consortium reaches milestone of 1,000 authorized users

Stand Up To Cancer Canada Announces New Cancer Stem Cell Dream Team To Attack Brain Cancer in Children and Adults

OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers

The Ontario Institute for Cancer Research and the Structural Genomics Consortium develop and give away new drug-like molecule to help crowd-source cancer research

Cancer patients treated in world-first clinical trial of Canadian viral therapy

The Ontario Institute for Cancer Research invests $4.6 million to support pancreatic cancer research